Recent News

• 05.28.2025 - Century Therapeutics Announces Two Upcoming Presentations at the EULAR 2025 Congress
• 05.28.2025 - Century Therapeutics Announces Two Upcoming Presentations at the EULAR 2025 Congress
• 05.15.2025 - Century Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
• 05.15.2025 - Century Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
• 04.28.2025 - Century Therapeutics Announces Two Upcoming Presentations at the ASGCT 28th Annual Meeting
• 04.28.2025 - Century Therapeutics Announces Two Upcoming Presentations at the ASGCT 28th Annual Meeting
• 04.22.2025 - Century Therapeutics Fireside Chat
• 04.22.2025 - Century Therapeutics Fireside Chat

Recent Filings

• 05.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.16.2025 - 144 Report of proposed sale of securities
• 05.15.2025 - EX-99.1 EX-99.1
• 05.15.2025 - 8-K Current report
• 05.15.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.15.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.05.2025 - 144 Report of proposed sale of securities
• 04.22.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material